Gary Gellerman
Ariel University, Israel
Biography
Gary Gellerman has completed his PhD from Tel Aviv University in 1994 and joined Compugen Ltd. In 2000, he accepted VP, Molecular Diversity position in Compugen where he was responsible for developing drug discovery platform. In 2005, he moved to Ariel University, currently holding Deanship of Faculty of Natural Sciences. He has published more than 50 articles in reputed journals.
Abstract
Abstract : Novel targeted non-RGD cyclic peptide drug conjugates for treatment of human metastatic melanoma